Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis
Crossref DOI link: https://doi.org/10.2337/dc20-0498
Published Online: 2020-08-11
Published Print: 2020-09-01
Update policy: https://doi.org/10.2337/ada-journal-policies
Huthmacher, Jessica A.
Meier, Juris J.
Nauck, Michael A. http://orcid.org/0000-0002-5749-6954
Version of Record valid from 2020-08-20